Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 547 of 1,261
  1. US 10064933

    Recombinant rift valley fever (RVF) viruses and methods of use

    The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Sep 4, 2018 · Expires Aug 30, 2038

    granted
  2. US 10064900

    Methods of populating a gastrointestinal tract

    Seres Therapeutics, Inc. · Granted Sep 4, 2018 · Expires Aug 30, 2038

    granted
  3. US 10064923

    Therapeutic cancer vaccines derived from a novel dendritic cell line

    DCPRIME B.V. · Granted Sep 4, 2018 · Expires Aug 30, 2038

    granted
  4. US 10064914

    Mitochondrial-derived peptide MOTS3 regulates metabolism and cell survival

    The Regents of the University of California · Granted Sep 4, 2018 · Expires Aug 30, 2038

    granted
  5. US 10064894

    Cell preparations for extemporaneous use, useful for healing and rejuvenation in vivo

    RegenLab USA LLC · Granted Sep 4, 2018 · Expires Aug 30, 2038

    granted
  6. US 10064901

    Compositions and methods

    Seres Therapeutics, Inc. · Granted Sep 4, 2018 · Expires Aug 30, 2038

    granted
  7. US 10064889

    Mercapto-modified biocompatible macromolecule derivatives with low degree of mercapto-modification and the cross-linked materials and uses thereof

    BIOREGEN BIOMEDICAL (CHANGZHOU) CO., LTD. · Granted Sep 4, 2018 · Expires Aug 30, 2038

    granted
  8. US 10064862

    Antiviral axin stabilizer

    The Board of Regents for Oklahoma State University · Granted Sep 4, 2018 · Expires Aug 30, 2038

    granted
  9. US 10064845

    Compositions and methods of treating muscular dystrophy with thromboxane-A2 receptor antagonists

    Cumberland Pharmaceuticals Inc. · Granted Sep 4, 2018 · Expires Aug 30, 2038

    granted
  10. US 10064858

    Methods and compositions for treating bacterial infections with iron chelators

    The United States of America as represented by the Secretary of the Army · Granted Sep 4, 2018 · Expires Aug 30, 2038

    granted
  11. US 10064836

    Antiparasitic compositions and methods

    TYRATECH, INC. · Granted Sep 4, 2018 · Expires Aug 30, 2038

    granted
  12. US 10065981

    Sialic acid analogs

    Ultragenyx Pharmaceutical Inc. · Granted Sep 4, 2018 · Expires Aug 30, 2038

    granted
  13. US 10065952

    Valbenazine salts and polymorphs thereof

    Neurocrine Biosciences, Inc. · Granted Sep 4, 2018 · Expires Aug 30, 2038

    granted
  14. US 10066214

    Compositions and methods for enhancing virus replication

    TURNSTONE LIMITED PARTNERSHIP · Granted Sep 4, 2018 · Expires Aug 30, 2038

    granted
  15. US 10066228

    Oligonucleotides for treating expanded repeat diseases

    Sarepta Therapeutics, Inc. · Granted Sep 4, 2018 · Expires Aug 30, 2038

    granted
  16. US 10065928

    Quinolinone compound and use thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Sep 4, 2018 · Expires Aug 30, 2038

    granted
  17. US 10065934

    Substituted urea derivatives and pharmaceutical uses thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Sep 4, 2018 · Expires Aug 30, 2038

    granted
  18. US 10064961

    Method for producing a liquid pharmaceutical preparation

    SANOCHEMIA PHARMAZEUTIKA AG · Granted Sep 4, 2018 · Expires Aug 30, 2038

    granted
  19. US 10064942

    Copper-cysteamine and methods of use

    The Board of Regents of the University of Texas System · Granted Sep 4, 2018 · Expires Aug 30, 2038

    granted
  20. EP 3364975

    KOMBINATIONEN VON TRAZODON UND GABAPENTIN ZUR BEHANDLUNG VON SCHMERZEN

    ACRAF [IT] · Granted Aug 29, 2018 · Expires Aug 24, 2038

    granted
  21. US 10058572

    Placenta-derived multipotent stem cells

    The Regents of the University of California · Granted Aug 28, 2018 · Expires Aug 23, 2038

    granted
  22. US 10059713

    3-substituted 2-amino-indole derivatives

    Takeda Pharmaceutical Company Limited · Granted Aug 28, 2018 · Expires Aug 23, 2038

    granted
  23. US 10058546

    Pharmaceutical compositions of (R)-1-(2,2-difluorobenzo[D][1,3]dioxo1-5-y1)-N-(1-(2,3-dihydroxypropy1)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-y1)-1H-indol-5-y1) cyclopropanecarbox-amide and administration thereof

    Vertex Pharmaceuticals Incorporated · Granted Aug 28, 2018 · Expires Aug 23, 2038

    granted
  24. US 10058556

    Method of treatment of aggression

    Supernus Pharmaceuticals, Inc. · Granted Aug 28, 2018 · Expires Aug 23, 2038

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.